GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Biotechnology Assets BST.MC · EUR

Health Care · BME · 🇪🇸 Spain

Compare

0.21

+2.99%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Biotechnology Assets — daily BME:BST Delayed
Market value
€15.1m
Last close × shares
Volume
112.7k
Shares, 9 Nov 2026

About Biotechnology Assets

Its shares trade on BME under the ticker BST.MC. It has been listed since 14 June 2011. In the fiscal year to 31 December 2025, it reported revenue of €3.1m and a net loss of €1.9m. At that date it held total assets of €13.6m and shareholders' equity of €6.2m.

ADL Bionatur Solutions SA operates as a biopharmaceutical company. The company is headquartered in Jerez De La Frontera, Cadiz. The company went IPO on 2011-06-14. Among the chemical projects, the Company comprises the examination and interpretation of samples from waste treatment works, valuation of biological activities and retrosynthetic analysis. The firm's subsidiaries are BBD BioPhenix SL, a San Sebastian-based biotechnology company and Zera Intein Protein Solutions SL.

Figures and description from our data supplier, not checked against the company's own report.

More about Biotechnology Assets →

Latest on Biotechnology Assets

Our reporting

We have not reported on Biotechnology Assets yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Biotechnology Assets's ticker?

Biotechnology Assets trades as BST.MC on BME, under ISIN ES0184980003.

What was Biotechnology Assets's last closing price?

0.21 on 9 Nov 2026. The figure is in EUR and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.